| Financial Year |
March 31 2023 |
| Monetary Funds |
2,977,915,992.38 |
| Held-for-trading Financial Assets |
65,507,012.75 |
| Notes Receivable |
-- |
| Accounts Receivable |
62,147,118.77 |
| Advances to Suppliers |
90,827,836.02 |
| Other Receivables |
134,887,227.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
323,840,339.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
41,807,059.38 |
| Total Current Assets |
3,696,932,586.68 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
208,055,070.68 |
| Investment Properties |
510,128,963.32 |
| Fixed Assetes |
1,004,901,831.10 |
| Under-construction Projects |
1,711,955.46 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
64,794,109.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
98,226,413.99 |
| Deferred Income Tax Assets |
722,494,540.15 |
| Other Non-Current Assets |
20,998,121.80 |
| Sub-Total of Non-Current Assets |
5,574,334,162.89 |
| Total Assets |
9,271,266,749.57 |
| Short-Term Loans |
500,406,805.18 |
| Trading Financial liabilities |
-- |
| Notes Payable |
150,000,000.00 |
| Accounts Payable |
468,265,522.24 |
| Accounts Received In Advance |
31,485,356.71 |
| Employee Compensation Payable |
10,881,545.58 |
| Taxes Payable |
35,884,511.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
262,444,560.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
355,130,862.52 |
| Other Current Liabilities |
2,525,317.23 |
| Sub-Total of Current Liabilities |
2,623,468,198.21 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,634,684.94 |
| Deferred Income Tax Liabilities |
586,125,145.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,626,820,655.19 |
| Total Liabilities |
5,250,288,853.40 |
| Paid-In Capital(Or Share Stock) |
704,038,932.00 |
| Capital Surplus |
1,745,985,196.09 |
| Surplus Reserve |
395,934,907.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,100,123,690.20 |
| Minority Stockholder's Interest |
14,558,280.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,006,419,615.78 |
| Owner's Equity（Stockholder's Equity） |
4,020,977,896.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,271,266,749.57 |
